nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketamine—CYP3A4—bone cancer	0.698	1	CbGaD
Ketamine—CYP2B6—Cisplatin—bone cancer	0.0311	0.278	CbGbCtD
Ketamine—CYP2B6—Doxorubicin—bone cancer	0.0208	0.187	CbGbCtD
Ketamine—CYP2C9—Cisplatin—bone cancer	0.0164	0.147	CbGbCtD
Ketamine—ABCB1—Cisplatin—bone cancer	0.0159	0.143	CbGbCtD
Ketamine—Clonus—Cisplatin—bone cancer	0.0127	0.271	CcSEcCtD
Ketamine—ABCB1—Doxorubicin—bone cancer	0.0107	0.0956	CbGbCtD
Ketamine—ABCB1—Methotrexate—bone cancer	0.0103	0.0926	CbGbCtD
Ketamine—CYP3A4—Doxorubicin—bone cancer	0.0064	0.0573	CbGbCtD
Ketamine—Obstructive airways disorder—Methotrexate—bone cancer	0.00353	0.0755	CcSEcCtD
Ketamine—TACR1—trigeminal nerve—bone cancer	0.00323	0.361	CbGeAlD
Ketamine—TACR1—cranial nerve—bone cancer	0.0023	0.257	CbGeAlD
Ketamine—Pain—Carboplatin—bone cancer	0.00152	0.0325	CcSEcCtD
Ketamine—Nystagmus—Epirubicin—bone cancer	0.00105	0.0225	CcSEcCtD
Ketamine—Nystagmus—Doxorubicin—bone cancer	0.000973	0.0208	CcSEcCtD
Ketamine—Apnoea—Methotrexate—bone cancer	0.000946	0.0202	CcSEcCtD
Ketamine—Cystitis noninfective—Methotrexate—bone cancer	0.000784	0.0167	CcSEcCtD
Ketamine—Cystitis—Methotrexate—bone cancer	0.000775	0.0165	CcSEcCtD
Ketamine—Bradycardia—Cisplatin—bone cancer	0.000747	0.016	CcSEcCtD
Ketamine—Cystitis noninfective—Epirubicin—bone cancer	0.000733	0.0157	CcSEcCtD
Ketamine—Salivary hypersecretion—Epirubicin—bone cancer	0.000729	0.0156	CcSEcCtD
Ketamine—Bladder pain—Methotrexate—bone cancer	0.000725	0.0155	CcSEcCtD
Ketamine—Cystitis—Epirubicin—bone cancer	0.000725	0.0155	CcSEcCtD
Ketamine—Bladder pain—Epirubicin—bone cancer	0.000679	0.0145	CcSEcCtD
Ketamine—Cystitis noninfective—Doxorubicin—bone cancer	0.000679	0.0145	CcSEcCtD
Ketamine—Salivary hypersecretion—Doxorubicin—bone cancer	0.000675	0.0144	CcSEcCtD
Ketamine—Cystitis—Doxorubicin—bone cancer	0.000671	0.0143	CcSEcCtD
Ketamine—Arrhythmia—Cisplatin—bone cancer	0.000656	0.014	CcSEcCtD
Ketamine—Erythema—Cisplatin—bone cancer	0.000639	0.0137	CcSEcCtD
Ketamine—Bladder pain—Doxorubicin—bone cancer	0.000628	0.0134	CcSEcCtD
Ketamine—Vision blurred—Cisplatin—bone cancer	0.000602	0.0129	CcSEcCtD
Ketamine—Convulsion—Cisplatin—bone cancer	0.000554	0.0118	CcSEcCtD
Ketamine—Diplopia—Epirubicin—bone cancer	0.000545	0.0116	CcSEcCtD
Ketamine—Anaphylactic shock—Cisplatin—bone cancer	0.000522	0.0111	CcSEcCtD
Ketamine—Diplopia—Doxorubicin—bone cancer	0.000504	0.0108	CcSEcCtD
Ketamine—Anorexia—Cisplatin—bone cancer	0.000497	0.0106	CcSEcCtD
Ketamine—Hypotension—Cisplatin—bone cancer	0.000487	0.0104	CcSEcCtD
Ketamine—TACR1—connective tissue—bone cancer	0.000475	0.0531	CbGeAlD
Ketamine—Decreased appetite—Cisplatin—bone cancer	0.000453	0.00969	CcSEcCtD
Ketamine—Pain—Cisplatin—bone cancer	0.000446	0.00953	CcSEcCtD
Ketamine—GRIN2D—tendon—bone cancer	0.0004	0.0448	CbGeAlD
Ketamine—GRIN2D—spinal cord—bone cancer	0.000386	0.0432	CbGeAlD
Ketamine—Bradycardia—Epirubicin—bone cancer	0.000384	0.0082	CcSEcCtD
Ketamine—Bradycardia—Doxorubicin—bone cancer	0.000355	0.00759	CcSEcCtD
Ketamine—Erythema—Methotrexate—bone cancer	0.000351	0.00749	CcSEcCtD
Ketamine—GRIN1—spinal cord—bone cancer	0.000344	0.0385	CbGeAlD
Ketamine—Arrhythmia—Epirubicin—bone cancer	0.000337	0.00719	CcSEcCtD
Ketamine—Vomiting—Cisplatin—bone cancer	0.000332	0.00708	CcSEcCtD
Ketamine—Vision blurred—Methotrexate—bone cancer	0.000331	0.00706	CcSEcCtD
Ketamine—Rash—Cisplatin—bone cancer	0.000329	0.00703	CcSEcCtD
Ketamine—Dermatitis—Cisplatin—bone cancer	0.000329	0.00702	CcSEcCtD
Ketamine—Erythema—Epirubicin—bone cancer	0.000328	0.00701	CcSEcCtD
Ketamine—GRIN2B—spinal cord—bone cancer	0.000328	0.0367	CbGeAlD
Ketamine—TACR1—spinal cord—bone cancer	0.000315	0.0352	CbGeAlD
Ketamine—Arrhythmia—Doxorubicin—bone cancer	0.000312	0.00666	CcSEcCtD
Ketamine—Nausea—Cisplatin—bone cancer	0.00031	0.00662	CcSEcCtD
Ketamine—Vision blurred—Epirubicin—bone cancer	0.000309	0.00661	CcSEcCtD
Ketamine—Convulsion—Methotrexate—bone cancer	0.000304	0.00649	CcSEcCtD
Ketamine—Erythema—Doxorubicin—bone cancer	0.000304	0.00649	CcSEcCtD
Ketamine—GRIN2A—tendon—bone cancer	0.000297	0.0333	CbGeAlD
Ketamine—GRIN2A—spinal cord—bone cancer	0.000287	0.0321	CbGeAlD
Ketamine—Anaphylactic shock—Methotrexate—bone cancer	0.000286	0.00611	CcSEcCtD
Ketamine—Vision blurred—Doxorubicin—bone cancer	0.000286	0.00611	CcSEcCtD
Ketamine—Convulsion—Epirubicin—bone cancer	0.000284	0.00607	CcSEcCtD
Ketamine—Anorexia—Methotrexate—bone cancer	0.000273	0.00583	CcSEcCtD
Ketamine—Anaphylactic shock—Epirubicin—bone cancer	0.000268	0.00572	CcSEcCtD
Ketamine—Hypotension—Methotrexate—bone cancer	0.000267	0.00571	CcSEcCtD
Ketamine—Shock—Epirubicin—bone cancer	0.000264	0.00563	CcSEcCtD
Ketamine—Convulsion—Doxorubicin—bone cancer	0.000263	0.00562	CcSEcCtD
Ketamine—Anorexia—Epirubicin—bone cancer	0.000255	0.00545	CcSEcCtD
Ketamine—Hypotension—Epirubicin—bone cancer	0.00025	0.00535	CcSEcCtD
Ketamine—Decreased appetite—Methotrexate—bone cancer	0.000249	0.00531	CcSEcCtD
Ketamine—Anaphylactic shock—Doxorubicin—bone cancer	0.000248	0.00529	CcSEcCtD
Ketamine—Pain—Methotrexate—bone cancer	0.000245	0.00523	CcSEcCtD
Ketamine—Shock—Doxorubicin—bone cancer	0.000244	0.00521	CcSEcCtD
Ketamine—Anorexia—Doxorubicin—bone cancer	0.000236	0.00505	CcSEcCtD
Ketamine—Decreased appetite—Epirubicin—bone cancer	0.000233	0.00497	CcSEcCtD
Ketamine—Hypotension—Doxorubicin—bone cancer	0.000232	0.00495	CcSEcCtD
Ketamine—Pain—Epirubicin—bone cancer	0.000229	0.00489	CcSEcCtD
Ketamine—Decreased appetite—Doxorubicin—bone cancer	0.000215	0.0046	CcSEcCtD
Ketamine—Pain—Doxorubicin—bone cancer	0.000212	0.00453	CcSEcCtD
Ketamine—GRIN1—Spinal Cord Injury—EGFR—bone cancer	0.000199	0.00148	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—SMO—bone cancer	0.000198	0.00148	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—RGS1—bone cancer	0.000192	0.00143	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—GRM4—bone cancer	0.000192	0.00143	CbGpPWpGaD
Ketamine—OPRK1—GPCR ligand binding—SMO—bone cancer	0.000191	0.00142	CbGpPWpGaD
Ketamine—GRIN1—Transmission across Chemical Synapses—MDM2—bone cancer	0.000191	0.00142	CbGpPWpGaD
Ketamine—OPRM1—TCR Signaling Pathway—JUN—bone cancer	0.00019	0.00142	CbGpPWpGaD
Ketamine—GRIN2B—Transmission across Chemical Synapses—MDM2—bone cancer	0.000186	0.00139	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—RGS1—bone cancer	0.000183	0.00136	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—GRM4—bone cancer	0.000183	0.00136	CbGpPWpGaD
Ketamine—Vomiting—Methotrexate—bone cancer	0.000182	0.00389	CcSEcCtD
Ketamine—CYP2C8—Arachidonic acid metabolism—PTGS2—bone cancer	0.000182	0.00135	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—GNA11—bone cancer	0.000181	0.00135	CbGpPWpGaD
Ketamine—TACR1—GPCR downstream signaling—IL3—bone cancer	0.000181	0.00135	CbGpPWpGaD
Ketamine—Rash—Methotrexate—bone cancer	0.00018	0.00386	CcSEcCtD
Ketamine—CYP2B6—Biological oxidations—CYP3A4—bone cancer	0.00018	0.00134	CbGpPWpGaD
Ketamine—Dermatitis—Methotrexate—bone cancer	0.00018	0.00385	CcSEcCtD
Ketamine—PTGS1—Selenium Micronutrient Network—PTGS2—bone cancer	0.000179	0.00133	CbGpPWpGaD
Ketamine—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	0.000179	0.00133	CbGpPWpGaD
Ketamine—CYP2B6—Metapathway biotransformation—CYP3A4—bone cancer	0.000178	0.00133	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—GRM4—bone cancer	0.000177	0.00132	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—RGS1—bone cancer	0.000177	0.00132	CbGpPWpGaD
Ketamine—GRIN1—Axon guidance—MET—bone cancer	0.000175	0.0013	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—GRM1—bone cancer	0.000175	0.0013	CbGpPWpGaD
Ketamine—GRIN1—Neuronal System—BRAF—bone cancer	0.000175	0.0013	CbGpPWpGaD
Ketamine—OPRM1—spinal cord—bone cancer	0.000174	0.0195	CbGeAlD
Ketamine—DRD2—GPCR ligand binding—GRM1—bone cancer	0.000174	0.00129	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.000174	0.00129	CbGpPWpGaD
Ketamine—GRIN2B—Axon guidance—MET—bone cancer	0.000171	0.00127	CbGpPWpGaD
Ketamine—Vomiting—Epirubicin—bone cancer	0.00017	0.00364	CcSEcCtD
Ketamine—GRIN2B—Neuronal System—BRAF—bone cancer	0.00017	0.00127	CbGpPWpGaD
Ketamine—Nausea—Methotrexate—bone cancer	0.00017	0.00363	CcSEcCtD
Ketamine—Rash—Epirubicin—bone cancer	0.000169	0.00361	CcSEcCtD
Ketamine—Dermatitis—Epirubicin—bone cancer	0.000169	0.0036	CcSEcCtD
Ketamine—GRIN2A—Neuronal System—MDM2—bone cancer	0.000168	0.00125	CbGpPWpGaD
Ketamine—GRIN1—Spinal Cord Injury—TP53—bone cancer	0.000167	0.00124	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—GRM1—bone cancer	0.000166	0.00124	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—IL3—bone cancer	0.000165	0.00123	CbGpPWpGaD
Ketamine—OPRM1—GPCR ligand binding—SMO—bone cancer	0.000161	0.0012	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—GRM4—bone cancer	0.00016	0.0012	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—RGS1—bone cancer	0.00016	0.0012	CbGpPWpGaD
Ketamine—Nausea—Epirubicin—bone cancer	0.000159	0.0034	CcSEcCtD
Ketamine—OPRD1—Signaling by GPCR—GRM1—bone cancer	0.000159	0.00118	CbGpPWpGaD
Ketamine—Vomiting—Doxorubicin—bone cancer	0.000158	0.00337	CcSEcCtD
Ketamine—Rash—Doxorubicin—bone cancer	0.000156	0.00334	CcSEcCtD
Ketamine—Dermatitis—Doxorubicin—bone cancer	0.000156	0.00334	CcSEcCtD
Ketamine—CYP2B6—Biological oxidations—GSTP1—bone cancer	0.000154	0.00115	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—GRM1—bone cancer	0.000153	0.00114	CbGpPWpGaD
Ketamine—CYP2C8—Biological oxidations—CYP3A4—bone cancer	0.000153	0.00114	CbGpPWpGaD
Ketamine—CYP2B6—Metapathway biotransformation—GSTP1—bone cancer	0.000152	0.00113	CbGpPWpGaD
Ketamine—CYP2C8—Metapathway biotransformation—CYP3A4—bone cancer	0.000151	0.00112	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—RGS1—bone cancer	0.000149	0.00111	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—GRM4—bone cancer	0.000149	0.00111	CbGpPWpGaD
Ketamine—CYP2C9—Arachidonic acid metabolism—PTGS2—bone cancer	0.000148	0.0011	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.000148	0.0011	CbGpPWpGaD
Ketamine—Nausea—Doxorubicin—bone cancer	0.000147	0.00314	CcSEcCtD
Ketamine—GRIN1—Neuronal System—MDM2—bone cancer	0.000146	0.00109	CbGpPWpGaD
Ketamine—GRIN1—Axon guidance—MMP2—bone cancer	0.000146	0.00109	CbGpPWpGaD
Ketamine—GRIN2B—Neuronal System—MDM2—bone cancer	0.000143	0.00106	CbGpPWpGaD
Ketamine—GRIN2B—Axon guidance—MMP2—bone cancer	0.000142	0.00106	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—NDUFA12—bone cancer	0.000142	0.00106	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—GRM1—bone cancer	0.000139	0.00104	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—RGS1—bone cancer	0.000136	0.00101	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—GRM4—bone cancer	0.000136	0.00101	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	0.000134	0.001	CbGpPWpGaD
Ketamine—CYP2C8—Biological oxidations—GSTP1—bone cancer	0.000131	0.000973	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—GRM1—bone cancer	0.000129	0.000964	CbGpPWpGaD
Ketamine—CYP2C8—Metapathway biotransformation—GSTP1—bone cancer	0.000129	0.00096	CbGpPWpGaD
Ketamine—PTGS1—connective tissue—bone cancer	0.000128	0.0144	CbGeAlD
Ketamine—GRIN1—Developmental Biology—CDK4—bone cancer	0.000125	0.000931	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—MET—bone cancer	0.000125	0.000931	CbGpPWpGaD
Ketamine—CYP2C9—Biological oxidations—CYP3A4—bone cancer	0.000124	0.000926	CbGpPWpGaD
Ketamine—CYP2C9—Metapathway biotransformation—CYP3A4—bone cancer	0.000123	0.000914	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	0.000122	0.000912	CbGpPWpGaD
Ketamine—DRD2—GPCR ligand binding—SMO—bone cancer	0.000122	0.000911	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—MET—bone cancer	0.000122	0.000907	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—CDK4—bone cancer	0.000122	0.000907	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	0.000121	0.000899	CbGpPWpGaD
Ketamine—DRD2—Circadian rythm related genes—CDK4—bone cancer	0.000118	0.000877	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—GRM1—bone cancer	0.000118	0.000876	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—NT5C3A—bone cancer	0.000117	0.000875	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—SMO—bone cancer	0.000117	0.000873	CbGpPWpGaD
Ketamine—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	0.000114	0.000852	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—GRM4—bone cancer	0.000113	0.000843	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—RGS1—bone cancer	0.000113	0.000843	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—GNA11—bone cancer	0.000113	0.000839	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—SMO—bone cancer	0.000112	0.000833	CbGpPWpGaD
Ketamine—GRIN1—Axon guidance—MMP9—bone cancer	0.00011	0.000818	CbGpPWpGaD
Ketamine—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	0.000108	0.000806	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—NDUFA12—bone cancer	0.000108	0.000806	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—GRM4—bone cancer	0.000108	0.000805	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—RGS1—bone cancer	0.000108	0.000805	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—GNA11—bone cancer	0.000107	0.000799	CbGpPWpGaD
Ketamine—GRIN2B—Axon guidance—MMP9—bone cancer	0.000107	0.000797	CbGpPWpGaD
Ketamine—CYP2C9—Biological oxidations—GSTP1—bone cancer	0.000106	0.000792	CbGpPWpGaD
Ketamine—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	0.000105	0.000781	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—MMP2—bone cancer	0.000104	0.000776	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—RGS1—bone cancer	0.000103	0.000765	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—GRM4—bone cancer	0.000103	0.000765	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	0.000102	0.000762	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—GNA11—bone cancer	0.000102	0.000761	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—IL3—bone cancer	0.000102	0.00076	CbGpPWpGaD
Ketamine—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000102	0.00076	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—MMP2—bone cancer	0.000102	0.000757	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—ATF1—bone cancer	9.97e-05	0.000742	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—GNA11—bone cancer	9.87e-05	0.000735	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—GRM1—bone cancer	9.81e-05	0.000731	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—SMO—bone cancer	9.8e-05	0.00073	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—IL3—bone cancer	9.72e-05	0.000724	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—GRM4—bone cancer	9.48e-05	0.000706	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—RGS1—bone cancer	9.48e-05	0.000706	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—GRM1—bone cancer	9.37e-05	0.000698	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—IL3—bone cancer	9.27e-05	0.00069	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—NDUFA12—bone cancer	9.16e-05	0.000682	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—GNA11—bone cancer	8.96e-05	0.000668	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—NT5C3A—bone cancer	8.96e-05	0.000668	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—IL3—bone cancer	8.95e-05	0.000667	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—GRM1—bone cancer	8.91e-05	0.000664	CbGpPWpGaD
Ketamine—GRIN1—Axon guidance—EGFR—bone cancer	8.87e-05	0.000661	CbGpPWpGaD
Ketamine—PTGS1—tendon—bone cancer	8.82e-05	0.00987	CbGeAlD
Ketamine—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	8.81e-05	0.000656	CbGpPWpGaD
Ketamine—GRIN2B—Axon guidance—EGFR—bone cancer	8.64e-05	0.000644	CbGpPWpGaD
Ketamine—PTGS1—spinal cord—bone cancer	8.51e-05	0.00952	CbGeAlD
Ketamine—OPRM1—GPCR downstream signaling—GNA11—bone cancer	8.34e-05	0.000621	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—TGFBR2—bone cancer	8.31e-05	0.000619	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—SMO—bone cancer	8.28e-05	0.000617	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—GRM1—bone cancer	8.22e-05	0.000612	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—IL3—bone cancer	8.12e-05	0.000605	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—GRM4—bone cancer	8.01e-05	0.000597	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—RGS1—bone cancer	8.01e-05	0.000597	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—NDUFA12—bone cancer	7.98e-05	0.000594	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—MMP9—bone cancer	7.83e-05	0.000583	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—IGF1R—bone cancer	7.82e-05	0.000583	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—MMP9—bone cancer	7.63e-05	0.000569	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	7.59e-05	0.000565	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—NT5C3A—bone cancer	7.59e-05	0.000565	CbGpPWpGaD
Ketamine—DRD2—Circadian rythm related genes—JUN—bone cancer	7.58e-05	0.000565	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—GNA11—bone cancer	7.57e-05	0.000564	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—IL3—bone cancer	7.56e-05	0.000563	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—NDUFA12—bone cancer	7.45e-05	0.000555	CbGpPWpGaD
Ketamine—CYP3A4—Biological oxidations—GSTP1—bone cancer	7.01e-05	0.000522	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—GRM1—bone cancer	6.94e-05	0.000517	CbGpPWpGaD
Ketamine—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	6.92e-05	0.000515	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—IL3—bone cancer	6.87e-05	0.000512	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—NT5C3A—bone cancer	6.61e-05	0.000492	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—SMO—bone cancer	6.6e-05	0.000492	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—EGFR—bone cancer	6.33e-05	0.000471	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—GNA11—bone cancer	6.32e-05	0.000471	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—SMO—bone cancer	6.28e-05	0.000468	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—NT5C3A—bone cancer	6.17e-05	0.00046	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—EGFR—bone cancer	6.17e-05	0.00046	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—RGS1—bone cancer	6.07e-05	0.000452	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—GRM4—bone cancer	6.07e-05	0.000452	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—GNA11—bone cancer	6.04e-05	0.00045	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—SMO—bone cancer	5.79e-05	0.000431	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—GNA11—bone cancer	5.74e-05	0.000428	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—IL3—bone cancer	5.73e-05	0.000427	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—KIT—bone cancer	5.67e-05	0.000423	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	5.62e-05	0.000419	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—ATF1—bone cancer	5.61e-05	0.000418	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—IL3—bone cancer	5.47e-05	0.000408	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	5.42e-05	0.000404	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—BRAF—bone cancer	5.33e-05	0.000397	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—GNA11—bone cancer	5.29e-05	0.000394	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—GRM1—bone cancer	5.26e-05	0.000392	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—IL3—bone cancer	5.2e-05	0.000388	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—EGFR—bone cancer	5.17e-05	0.000385	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—ENO2—bone cancer	5.14e-05	0.000383	CbGpPWpGaD
Ketamine—ABCB1—bone marrow—bone cancer	5.05e-05	0.00565	CbGeAlD
Ketamine—ABCB1—spinal cord—bone cancer	5.03e-05	0.00563	CbGeAlD
Ketamine—DRD2—Circadian rythm related genes—TP53—bone cancer	5e-05	0.000373	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—ATF1—bone cancer	4.92e-05	0.000367	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—NDUFA12—bone cancer	4.91e-05	0.000366	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—SMO—bone cancer	4.89e-05	0.000364	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	4.89e-05	0.000364	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—IL3—bone cancer	4.8e-05	0.000358	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—DHFR—bone cancer	4.77e-05	0.000356	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—TGFBR2—bone cancer	4.68e-05	0.000349	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—GNA11—bone cancer	4.47e-05	0.000333	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—MDM2—bone cancer	4.47e-05	0.000333	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—GNA11—bone cancer	4.46e-05	0.000332	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—IGF1R—bone cancer	4.4e-05	0.000328	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—ATF1—bone cancer	4.16e-05	0.00031	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—TGFBR2—bone cancer	4.1e-05	0.000306	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—NT5C3A—bone cancer	4.07e-05	0.000303	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—IL3—bone cancer	4.06e-05	0.000302	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—CYP3A4—bone cancer	4.04e-05	0.000301	CbGpPWpGaD
Ketamine—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	4.02e-05	0.0003	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—ENO2—bone cancer	3.93e-05	0.000292	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—JUN—bone cancer	3.88e-05	0.000289	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—IGF1R—bone cancer	3.86e-05	0.000288	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	3.84e-05	0.000286	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—MMP9—bone cancer	3.78e-05	0.000281	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—SMO—bone cancer	3.71e-05	0.000276	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—DHFR—bone cancer	3.64e-05	0.000271	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—TGFBR2—bone cancer	3.47e-05	0.000258	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—GSTP1—bone cancer	3.46e-05	0.000258	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—GNA11—bone cancer	3.4e-05	0.000254	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—GNA11—bone cancer	3.39e-05	0.000253	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—ENO2—bone cancer	3.32e-05	0.000248	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—IGF1R—bone cancer	3.26e-05	0.000243	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	3.23e-05	0.00024	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—KIT—bone cancer	3.19e-05	0.000238	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—ATF1—bone cancer	3.15e-05	0.000235	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—CYP3A4—bone cancer	3.09e-05	0.00023	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—DHFR—bone cancer	3.08e-05	0.00023	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—IL3—bone cancer	3.07e-05	0.000229	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—EGFR—bone cancer	3.05e-05	0.000227	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—BRAF—bone cancer	3e-05	0.000224	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—EGFR—bone cancer	2.91e-05	0.000217	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—ENO2—bone cancer	2.9e-05	0.000216	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—GNA11—bone cancer	2.88e-05	0.000215	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—KIT—bone cancer	2.8e-05	0.000209	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—ENO2—bone cancer	2.7e-05	0.000202	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—DHFR—bone cancer	2.69e-05	0.0002	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—GSTP1—bone cancer	2.64e-05	0.000197	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—BRAF—bone cancer	2.63e-05	0.000196	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—TGFBR2—bone cancer	2.63e-05	0.000196	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—CYP3A4—bone cancer	2.61e-05	0.000195	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.6e-05	0.000194	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—TP53—bone cancer	2.56e-05	0.000191	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—EGFR—bone cancer	2.55e-05	0.00019	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—MDM2—bone cancer	2.52e-05	0.000187	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—GNA11—bone cancer	2.51e-05	0.000187	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—DHFR—bone cancer	2.51e-05	0.000187	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—IGF1R—bone cancer	2.47e-05	0.000184	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—KIT—bone cancer	2.37e-05	0.000176	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—GNA11—bone cancer	2.35e-05	0.000175	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—CYP3A4—bone cancer	2.28e-05	0.00017	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—GSTP1—bone cancer	2.23e-05	0.000166	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—BRAF—bone cancer	2.23e-05	0.000166	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—MDM2—bone cancer	2.21e-05	0.000164	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—JUN—bone cancer	2.19e-05	0.000163	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—EGFR—bone cancer	2.16e-05	0.000161	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—MMP9—bone cancer	2.13e-05	0.000159	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—CYP3A4—bone cancer	2.13e-05	0.000158	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.12e-05	0.000158	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—GSTP1—bone cancer	1.95e-05	0.000145	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—JUN—bone cancer	1.92e-05	0.000143	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—MMP9—bone cancer	1.87e-05	0.000139	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MDM2—bone cancer	1.86e-05	0.000139	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—GSTP1—bone cancer	1.82e-05	0.000135	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—KIT—bone cancer	1.79e-05	0.000134	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—PTGS2—bone cancer	1.79e-05	0.000134	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ENO2—bone cancer	1.78e-05	0.000133	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—EGFR—bone cancer	1.72e-05	0.000128	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—BRAF—bone cancer	1.69e-05	0.000126	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—DHFR—bone cancer	1.65e-05	0.000123	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—EGFR—bone cancer	1.63e-05	0.000122	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—JUN—bone cancer	1.62e-05	0.000121	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MMP9—bone cancer	1.58e-05	0.000117	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—GNA11—bone cancer	1.55e-05	0.000115	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—EGFR—bone cancer	1.51e-05	0.000112	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—TP53—bone cancer	1.44e-05	0.000108	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MDM2—bone cancer	1.41e-05	0.000105	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PTGS2—bone cancer	1.37e-05	0.000102	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—EGFR—bone cancer	1.27e-05	9.49e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—TP53—bone cancer	1.27e-05	9.43e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—JUN—bone cancer	1.23e-05	9.15e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—GSTP1—bone cancer	1.2e-05	8.93e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MMP9—bone cancer	1.19e-05	8.9e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PTGS2—bone cancer	1.16e-05	8.62e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—TP53—bone cancer	1.07e-05	7.97e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PTGS2—bone cancer	1.01e-05	7.51e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—EGFR—bone cancer	9.66e-06	7.19e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PTGS2—bone cancer	9.42e-06	7.02e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—TP53—bone cancer	8.11e-06	6.04e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PTGS2—bone cancer	6.21e-06	4.63e-05	CbGpPWpGaD
